Search results for "pine"

showing 10 items of 2022 documents

Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chro…

2005

Increased levels of tumor necrosis factor-alpha (TNF-alpha) correlate with poor prognoses in chronic heart failure (CHF). This study demonstrated that noradrenaline and isoproterenol inhibit TNF-alpha production in patients with CHF in ex vivo whole blood in a dose-dependent fashion. The beta-blocker bisoprolol abolishes this effect.

AdultLipopolysaccharidesMalemedicine.medical_specialtyLipopolysaccharideAdrenergic receptorAdrenergic beta-AntagonistsNorepinephrinechemistry.chemical_compoundInternal medicineReceptors Adrenergic betamedicineBisoprololHumansReceptorWhole bloodHeart FailureTumor Necrosis Factor-alphabusiness.industryIsoproterenolCardiovascular Agentsmedicine.diseaseEndocrinologychemistryBisoprololHeart failurecardiovascular systemCardiologyFemaleTumor necrosis factor alphaCardiology and Cardiovascular MedicinebusinessEx vivomedicine.drugThe American Journal of Cardiology
researchProduct

Double Retrotransverse Foramen of Atlas (C1)

2018

Background The retrotransverse foramen is a nonmetric variant of C1 that consists of an abnormal accessory foramen on the posterior root of the transverse process. Case Description During a study on the prevalence of the retrotransverse foramen in 150 dry C1 vertebrae, we observed an exceptional C1 (0.67%) with a right double retrotransverse foramen of the 14 C1 vertebrae (9.3%). This has not been reported previously in the literature. No osteogenic reaction and no degenerative signs were observed in this C1 with the double retrotransverse foramen. Conclusions Neurosurgeons should be aware of the possible presence of the “conventional” retrotransverse foramen and the “exceptional” double re…

AdultMale0301 basic medicinecongenital hereditary and neonatal diseases and abnormalitiesYoung Adult03 medical and health sciences0302 clinical medicinestomatognathic systemAtlas (anatomy)ForamenHumansMedicineProspective StudiesCervical AtlasAgedAged 80 and overbusiness.industryAnatomyMiddle AgedCase descriptionmusculoskeletal systemCervical spinePatient managementbody regionsmedicine.anatomical_structureFemaleSurgery030101 anatomy & morphologyNeurology (clinical)businessPosterior root030217 neurology & neurosurgeryWorld Neurosurgery
researchProduct

Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.

2017

The treatment of neuropathic pain due to low-back (lumbosacral) radiculopathies, a common source of neuropathic pain, is challenging and often requires a multimodal therapeutic approach. The capsaicin 8% patch is the first topical analgesic licensed for peripheral neuropathic pain. To evaluate this treatment, a subset of patients with painful radiculopathy (lumbar and cervical, including ventral and dorsal rami) enrolled into the multicenter, non-interventional QUEPP study (QutenzaOf the 1044 study participants, 50 were diagnosed with painful radiculopathy as only peripheral neuropathic pain syndrome and were eligible for evaluation. Patients received a single treatment (visit 1) with follo…

AdultMaleAdministration Cutaneous03 medical and health sciences0302 clinical medicineLumbarQuality of life030202 anesthesiologySurveys and QuestionnairesMedicineHumansRadiculopathyAgedReferred painbusiness.industryPruritusGeneral MedicineMiddle Agedmedicine.diseaseLow back painSpineTreatment OutcomeAnesthesiaNeuropathic painNeuralgiaQuality of LifeNeuralgiaFemalemedicine.symptomCapsaicinbusinessRadiculopathies030217 neurology & neurosurgeryLumbosacral jointCurrent medical research and opinion
researchProduct

Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors

1998

Pharmacokinetic interactions of clozapine and its metabolites N-desmethylclozapine and clozapine N-oxide with the selective serotonin reuptake inhibitors (SSRIs) fluvoxamine and paroxetine were investigated in a prospective study in schizophrenic patients under steady-state conditions. Thirty patients were treated with clozapine at a target dose of 2.5 to 3.0 mg/kg of body weight. After gradual dose escalation, serum concentrations of clozapine and two metabolites were determined twice at 7-day intervals after steady-state conditions had been reached. Then, fluvoxamine (50 mg/day) or paroxetine (20 mg/day) was added in 16 and 14 patients, respectively. Serum concentrations of clozapine and …

AdultMaleAdolescentFluvoxaminePharmacologyPharmacokineticsmedicineHumansDrug InteractionsPharmacology (medical)Prospective StudiesProspective cohort studyClozapineClozapinebusiness.industrySmokingMiddle AgedDrug interactionParoxetineParoxetinePsychiatry and Mental healthFluvoxamineSchizophreniaFemaleSerotoninbusinessReuptake inhibitorSelective Serotonin Reuptake InhibitorsAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Addition of Low-Dose Fluvoxamine to Low-Dose Clozapine Monotherapy in Schizophrenia: Drug Monitoring and Tolerability Data from a Prospective Clinica…

1999

Combining fluvoxamine and clozapine may be a strategy to improve therapeutic effects on negative symptoms in schizophrenic patients. Fluvoxamine, however, markedly inhibits the metabolism of clozapine, and hazardous side effects may result. This study prospectively investigated the safety and tolerability of an add-on therapy with fluvoxamine to a clozapine monotherapy in schizophrenic patients. Sixteen schizophrenic patients received 50 mg fluvoxamine as a comedication after having reached steady-state conditions under clozapine monotherapy. Patients were monitored for subjective adverse events, laboratory parameters, EEG and ECG recordings, orthostatic hypotension and their psychopatholog…

AdultMaleAdolescentMatched-Pair AnalysisFluvoxamineDrug Administration ScheduleOrthostatic vital signsmedicineHumansDrug InteractionsPharmacology (medical)Prospective StudiesAdverse effectClozapineClozapineTherapeutic effectGeneral MedicineMiddle AgedDrug interactionPsychiatry and Mental healthTreatment OutcomeTolerabilityFluvoxamineAnesthesiaSchizophreniaAntidepressive Agents Second-GenerationDrug Therapy CombinationFemaleDrug MonitoringPsychologyReuptake inhibitorSelective Serotonin Reuptake InhibitorsAntipsychotic Agentsmedicine.drugPharmacopsychiatry
researchProduct

Treatment of hypertension with a combination of nifedipine and atenolol compared with atenolol alone. Preliminary report.

1988

AdultMaleAdolescentNifedipinebusiness.industryPharmacology toxicologyBlood PressurePharmacologyMiddle AgedAtenololPharmacotherapyNifedipineAtenololPreliminary reportHypertensionmedicineHumansPharmacology (medical)Drug Therapy CombinationFemalebusinessmedicine.drugAgedDrugs
researchProduct

Effects of achievement goals on perceptions of competence in conditions of unfavourable social comparisons: The mastery goal advantage effect

2017

Background Previous prospective studies have documented that mastery-approach goals are adaptive because they facilitate less negative psychological responses to unfavourable social comparisons than performance-approach goals. Aims This study aimed to confirm this so-called ‘mastery goal advantage’ effect experimentally. Methods A 2 × 3 design was adopted where achievement goals (mastery vs. performance) and normative information (favourable vs. no-normative information vs. unfavourable) were manipulated as between participant factors. Sample Participants were 201 undergraduates, 57 males and 144 females, ranging in age from 17 to 55 years (Mage = 22.53, SD = 6.51). Results Regression analy…

AdultMaleAdolescentUniversitiesmedia_common.quotation_subjectmastery goal advantage effect050109 social psychologyAcademic achievementEducationYoung AdultSocial cognitionachievement goalsDevelopmental and Educational PsychologyHumansta5160501 psychology and cognitive sciencesStudentsta515media_commonSocial comparison theoryAcademic SuccessGoal orientation05 social sciences050301 educationMastery learningMiddle AgedSelf Efficacyunfavourable social comparisonsSocial Perceptionperceptions of competenceWell-beingHappinessFemaleSocial competencePsychologyGoals0503 educationSocial psychologyBritish Journal of Educational Psychology
researchProduct

An emotional Stroop task with faces and words. A comparison of young and older adults

2017

Abstract Antecedents Given the contradictions of previous studies on the changes in attentional responses produced in aging a Stroop emotional task was proposed to compare young and older adults to words or faces with an emotional valence. Method The words happy or sad were superimposed on faces that express the emotion of happiness or sadness. The emotion expressed by the word and the face could agree or not (cued and uncued trials, respectively). 85 young and 66 healthy older adults had to identify both faces and words separately, and the interference between the two types of stimuli was examined. Results An interference effect was observed for both types of stimuli in both groups. There …

AdultMaleAgingmedicine.medical_specialtyAdolescentmedia_common.quotation_subjectEmotionsExperimental and Cognitive PsychologyEmotional valenceAudiology050105 experimental psychologyYoung Adult03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Reading (process)Developmental and Educational PsychologymedicineHumansAttention0501 psychology and cognitive sciencesYoung adultAgedmedia_commonAged 80 and overCued speechFacial expression05 social sciencesAge FactorsMiddle AgedFacial ExpressionSadnessPattern Recognition VisualReadingStroop TestHappinessFemalePsychologyFacial RecognitionPsychomotor Performancepsychological phenomena and processes030217 neurology & neurosurgeryCognitive psychologyStroop effectConsciousness and Cognition
researchProduct

Driving habits and risk factors for traffic accidents among sleep apnea patients - a European multi-centre cohort study

2014

Obstructive sleep apnea is associated with increased motor vehicle accident risk, and improved detection of patients at risk is of importance. The present study addresses potential risk factors in the European Sleep Apnea Database and includes patients with suspected obstructive sleep apnea [n = 8476, age 51.5 (12.5) years, body mass index 31.0 (6.6) kg m(-2) , 82.4% driver's licence holders]. Driving distance (km year(-1) ), driver's licence type, sleep apnea severity, sleepiness and comorbidities were assessed. Previously validated risk factors for accident history: Epworth Sleepiness Scale ≥16; habitual sleep time ≤5 h; use of hypnotics; and driving ≥15 000 km year(-1) were analysed acro…

AdultMaleAutomobile DrivingPediatricsmedicine.medical_specialtyAdolescentDatabases FactualCognitive NeurosciencePoison controlSettore MED/10 - Malattie Dell'Apparato RespiratorioCohort StudiesYoung AdultBehavioral NeuroscienceRisk FactorsPrevalencedriving exposure hypersomnia motor vehicle crash registry sleepy driving traffic riskHumansMedicineAttentionRisk factorAgedAged 80 and overSleep Apnea Obstructivebusiness.industryEpworth Sleepiness ScaleAccidents TrafficSleep apneaApneaGeneral MedicineMiddle Agedmedicine.diseaseObesityEuropeObstructive sleep apneaFemaleMedical emergencymedicine.symptomSleepbusinessCohort studyJournal of Sleep Research
researchProduct

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis

2021

Background: Knowledge regarding the impact of body composition measures on pharmacokinetics of antipsychotics is limited. Aims: Our aim was to investigate the impact of body weight and body mass index on clozapine pharmacokinetics using a therapeutic drug monitoring database. Methods: A large therapeutic drug monitoring dataset of clozapine plasma concentrations considering three patient subgroups was analysed: a control group (CLZ0, 20–30 kg/m2, n=266), a group with high body mass index (CLZhigh, body mass index ⩾30 kg/m2, n=162) and with low body mass index values (CLZlow, body mass index <20 kg/m2, n=27). Comparisons of plasma and dose-adjusted plasma concentrations (C/D) of clozapine…

AdultMaleBiological AvailabilityPharmacologyBody weightBody Mass IndexYoung Adult03 medical and health sciencesSex Factors0302 clinical medicinePharmacokineticsmedicineHumansTissue DistributionPharmacology (medical)ObesityClozapineClozapineAgedRetrospective StudiesA determinantAged 80 and overPharmacologymedicine.diagnostic_testbusiness.industryBody WeightMiddle Agedmedicine.diseaseObesity030227 psychiatryPsychiatry and Mental healthAdipose TissueLiverTherapeutic drug monitoringPlasma concentrationFemaleDrug MonitoringbusinessBody mass index030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugJournal of Psychopharmacology
researchProduct